101st American Assoc for Cancer Research (AACR) Conference

date

2010

related documents

BCR-Abl tyrosine kinase inhibitor Nilotinib (Tasigna®) reverses ABCB1/Pgp- and ABCG2/BCRP-mediated multidrug resistance Conference Poster (Faculty180)
Tyrosine kinase inhibitors are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance Proceedings (Faculty180)

event location

Washington, DC